PubRank

T L Phillips

Author PubWeight™ 193.93‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys 2000 7.50
2 More on managing metastatic choroidal tumors. Oncology (Williston Park) 1989 5.12
3 Carcinoma of the cervix: predictive value of clinical and magnetic resonance (MR) imaging assessment of prognostic factors. Int J Radiat Oncol Biol Phys 1993 2.13
4 Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland. Radiat Res 1993 1.99
5 Radiation pneumonitis following combined modality therapy for lung cancer: analysis of prognostic factors. J Clin Oncol 1995 1.96
6 Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. Int J Radiat Oncol Biol Phys 1997 1.93
7 Carcinoma of the extrahepatic bile ducts. The University of California at San Francisco experience. Ann Surg 1994 1.72
8 Injury to the lung from cancer therapy: clinical syndromes, measurable endpoints, and potential scoring systems. Int J Radiat Oncol Biol Phys 1995 1.71
9 Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost +/- hyperthermia for glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1998 1.71
10 Experience in charged particle irradiation of tumors of the skull base: 1977-1992. Int J Radiat Oncol Biol Phys 1994 1.70
11 Uveal melanoma. Growth rate and prognosis. Arch Ophthalmol 1997 1.67
12 Gamma knife radiosurgery for malignant melanoma brain metastases. Cancer J Sci Am 1998 1.63
13 A randomized phase III protocol for the evaluation of misonidazole combined with radiation in the treatment of patients with brain metastases (RTOG-7916). Int J Radiat Oncol Biol Phys 1991 1.63
14 Transport of membrane-bound macromolecules by M cells in follicle-associated epithelium of rabbit Peyer's patch. Cell Tissue Res 1987 1.59
15 RTOG Late Effects Working Group. Overview. Late Effects of Normal Tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys 1995 1.57
16 High-dose-rate versus low-dose-rate intracavitary brachytherapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys 1990 1.56
17 Radiosurgery for brain metastases: is whole brain radiotherapy necessary? Int J Radiat Oncol Biol Phys 1999 1.50
18 Failure of preenucleation radiation to decrease uveal melanoma mortality. Am J Ophthalmol 1988 1.42
19 Vision following helium ion radiotherapy of uveal melanoma: a Northern California Oncology Group study. Int J Radiat Oncol Biol Phys 1988 1.39
20 Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost. Int J Radiat Oncol Biol Phys 1994 1.34
21 A Carboniferous insect gall: insight into early ecologic history of the Holometabola. Proc Natl Acad Sci U S A 1996 1.34
22 The neurotoxicity of misonidazole: pooling of data from five centres. Br J Radiol 1978 1.31
23 Desmoid tumors--treatment and prognosis. Radiology 1977 1.26
24 Economic evaluation of interventions to reduce road traffic injuries--a review of the literature with applications to low and middle-income countries. Asia Pac J Public Health 2004 1.26
25 Soft tissue sarcomas of the extremities: survival and patterns of failure with conservative surgery and postoperative irradiation compared to surgery alone. Cancer 1982 1.24
26 Large effect of age on the survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost. Neurosurgery 1995 1.21
27 An ultrastructural study of the development of radiation injury in the lung. Radiology 1966 1.21
28 Desmoid tumors: local control and patterns of relapse following radiation therapy. Int J Radiat Oncol Biol Phys 1983 1.17
29 Kidney cell proliferation after unilateral nephrectomy as related to age. Cancer Res 1967 1.16
30 Single-agent chemotherapy of a solid murine tumor assayed by growth delay and cell survival. Cancer Res 1980 1.16
31 Modification of radiation injury to normal tissues by chemotherapeutic agents. Cancer 1975 1.15
32 Malignant tumors of the testis: analysis of treatment results and sites and causes of failure. Cancer 1977 1.14
33 The neurotoxicity of misonidazole: potential modifying role of phenytoin sodium and dexamethasone. Br J Radiol 1980 1.12
34 Radiation retinopathy. Int J Radiat Oncol Biol Phys 1979 1.12
35 Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes. Cancer Res 1994 1.08
36 Radiation response of artificial pulmonary metastases of the EMT6 tumor. Int J Radiat Oncol Biol Phys 1976 1.08
37 Defining treatment margins for six field conformal irradiation of localized prostate cancer. Int J Radiat Oncol Biol Phys 1994 1.07
38 High intensity 125-iodine (125I) plaque treatment of uveal melanoma. Int J Radiat Oncol Biol Phys 1993 1.07
39 Stereotaxic irradiation of brain tumors. Cancer 1990 1.07
40 Initial United States clinical and pharmacologic evaluation of misonidazole (Ro-07-0582), an hypoxic cell radiosensitizer. Int J Radiat Oncol Biol Phys 1979 1.06
41 Prognostic factors in adult soft-tissue sarcomas of the head and neck. Int J Radiat Oncol Biol Phys 1997 1.05
42 Carcinoma of the major and minor salivary glands: analysis of treatment results and sites and causes of failures. Cancer 1977 1.05
43 Differential protection against cytotoxic chemotherapeutic effects on bone marrow CFUs by Wr-2721. Cancer Clin Trials 1981 1.04
44 Quantification of combined radiation therapy and chemotherapy effects on critical normal tissues. Cancer 1976 1.04
45 Time-dose relationships in the mouse esophagus. Radiology 1974 1.03
46 Identification of an optimal subgroup for treatment evaluation of patients with brain metastases using RTOG study 7916. Int J Radiat Oncol Biol Phys 1989 1.03
47 Radiation pneumonitis: a new approach to the derivation of time-dose factors. Cancer 1973 1.02
48 Neon ion radiotherapy: results of the phase I/II clinical trial. Int J Radiat Oncol Biol Phys 1991 1.02
49 Radiotherapy for high grade clinically localized adenocarcinoma of the prostate. J Urol 1996 1.02
50 Radiation tolerance of the spinal cord. Cancer 1975 1.01
51 Elevated IGA in carcinoma of the nasopharynx. Cancer 1975 1.00
52 Phase III trial of accelerated hyperfractionation with or without difluromethylornithine (DFMO) versus standard fractionated radiotherapy with or without DFMO for newly diagnosed patients with glioblastoma multiforme. Int J Radiat Oncol Biol Phys 2001 1.00
53 Should asymptomatic patients with inoperable bronchogenic carcinoma receive immediate radiotherapy? Yes. Am Rev Respir Dis 1978 0.99
54 High activity iodine-125 interstitial implant for gliomas. Int J Radiat Oncol Biol Phys 1992 0.99
55 EORTC Late Effects Working Group. Overview of late effects normal tissues (LENT) scoring system. Radiother Oncol 1995 0.99
56 The potential for adjuvant radiotherapy in choroidal melanoma. Arch Ophthalmol 1982 0.99
57 Effect of various doses of radiation for uveal melanoma on regression, visual acuity, complications, and survival. Am J Ophthalmol 1989 0.99
58 Treatment of cancer with heavy charged particles. Int J Radiat Oncol Biol Phys 1982 0.98
59 Highly anaplastic astrocytoma: a review of 357 patients treated between 1977 and 1989. Int J Radiat Oncol Biol Phys 1992 0.97
60 Results and prognostic factors in the retreatment of locally recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 1998 0.97
61 External irradiation followed by an interstitial high activity iodine-125 implant "boost" in the initial treatment of malignant gliomas: NCOG study 6G-82-2. Int J Radiat Oncol Biol Phys 1991 0.97
62 Uveal melanoma radiation. 125I brachytherapy versus helium ion irradiation. Ophthalmology 1989 0.96
63 Practical induction heating coil designs for clinical hyperthermia with ferromagnetic implants. IEEE Trans Biomed Eng 1994 0.96
64 Brachytherapy of recurrent malignant brain tumors with removable high-activity iodine-125 sources. J Neurosurg 1984 0.95
65 Improved freedom from PSA failure with whole pelvic irradiation for high-risk prostate cancer. Int J Radiat Oncol Biol Phys 1998 0.95
66 Survival comparison of radiosurgery-eligible and -ineligible malignant glioma patients treated with hyperfractionated radiation therapy and carmustine: a report of Radiation Therapy Oncology Group 83-02. J Clin Oncol 1993 0.94
67 Definitive postoperative irradiation of bile duct carcinoma with charged particles and/or photons. Int J Radiat Oncol Biol Phys 1993 0.94
68 Biologic rationale of combined radiotherapy and chemotherapy. Hematol Oncol Clin North Am 1991 0.93
69 Radiobiolgoical and biochemical studies of thiophosphate radioprotective compounds related to cysteamine. Radiat Res 1971 0.93
70 A comparison of misonidazole sensitized radiation therapy to radiation therapy alone for the palliation of hepatic metastases: results of a Radiation Therapy Oncology Group randomized prospective trial. Int J Radiat Oncol Biol Phys 1987 0.93
71 Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma. Int J Radiat Oncol Biol Phys 1998 0.92
72 Charged particle irradiation of sacral chordomas. Int J Radiat Oncol Biol Phys 1993 0.92
73 The significance of laryngeal edema following radiotherapy of carcinoma of the vocal cord. Cancer 1982 0.92
74 Charged particle irradiation of chordoma and chondrosarcoma of the base of skull and cervical spine: the Lawrence Berkeley Laboratory experience. Int J Radiat Oncol Biol Phys 1988 0.91
75 RTOG quality assurance guidelines for clinical trials using hyperthermia. Int J Radiat Oncol Biol Phys 1990 0.91
76 Palliation for carcinoma of the esophagus. Radiology 1976 0.91
77 Radiation-induced decrease in nitric oxide synthase--containing nerves in the rat penis. Radiology 1995 0.91
78 Radiation tolerance of the thoracic spinal cord. Am J Roentgenol Radium Ther Nucl Med 1969 0.91
79 Combination therapy of a solid murine tumor with cyclophosphamide and radiation: the effects of time, dose and assay method. Int J Radiat Oncol Biol Phys 1979 0.90
80 A quantitative technique for measuring renal damage after irradiation. Radiology 1973 0.89
81 Toxicity following high-dose three-dimensional conformal and intensity-modulated radiation therapy for clinically localized prostate cancer. Urology 2001 0.89
82 Tumor and normal tissue response to irradiation in vivo: variation with decreasing dose rates. Radiology 1975 0.89
83 Combined radiotherapy and chemotherapy with bleomycin and methotrexate for advanced inoperable head and neck cancer: update of a Northern California Oncology Group randomized trial. J Clin Oncol 1987 0.89
84 Rationale for initial clinical trials and future development of radioprotectors. Cancer Clin Trials 1980 0.89
85 A noninvasive eye fixation monitoring system for CyberKnife radiotherapy of choroidal and orbital tumors. Med Phys 2009 0.89
86 Therapy for hepatocellular cancer with intrahepatic arterial adriamycin and 5-fluorouracil combined with whole-liver irradiation: a Northern California Oncology Group Study. Cancer Treat Rep 1980 0.88
87 Differential radioprotection of euoxic and hypoxic mouse mammary tumors by a thiophosphate compound. Radiology 1974 0.88
88 Final report on the United States Phase I Clinical Trial of the hypoxic cell radiosensitizer, misonidazole (Ro-07-0582; NSC #261037). Cancer 1981 0.88
89 Interstitial thermoradiotherapy with ferromagnetic implants for locally advanced and recurrent neoplasms. Int J Radiat Oncol Biol Phys 1993 0.88
90 Biological effects of 15 MeV neutrons. Int J Radiat Oncol Biol Phys 1977 0.88
91 Genotypic analysis of Epstein-Barr virus isolates associated with nasopharyngeal carcinoma in Chinese immigrants to the United States. Int J Cancer 1994 0.88
92 Long-term results of helium ion irradiation of uveal melanoma. Int J Radiat Oncol Biol Phys 1990 0.87
93 The effects of combined bleomycin and irradiation on a solid murine tumor. Int J Radiat Oncol Biol Phys 1979 0.87
94 Final report of the phase I trial of the hypoxic cell radiosensitizer SR 2508 (etanidazole) Radiation Therapy Oncology Group 83-03. Int J Radiat Oncol Biol Phys 1990 0.87
95 The interaction of radiation and cis-diamminedichloroplatinum (II) in intestinal crypt cells. Int J Radiat Oncol Biol Phys 1979 0.87
96 Radiation therapy of desmoid tumors. Am J Roentgenol Radium Ther Nucl Med 1973 0.87
97 Randomized trial of radiation for age-related macular degeneration. Am J Ophthalmol 1999 0.86
98 Peripheral dose in ocular treatments with CyberKnife and Gamma Knife radiosurgery compared to proton radiotherapy. Phys Med Biol 2007 0.86
99 Radiotherapy with heavy charged particles at Lawrence Berkeley Laboratory. J Can Assoc Radiol 1980 0.86
100 Systemic factor in recovery of rat kidney from x-irradiation: thymidine-H3 incorporation studies. Radiat Res 1966 0.86
101 Radiation Therapy Oncology Group clinical trials with misonidazole. Cancer 1981 0.86
102 Current status of clinical particle radiotherapy at Lawrence Berkeley Laboratory. Cancer 1980 0.86
103 Changes in glycolytic enzyme levels and isozyme expression in human lymphocytes during blast transformation. Arch Biochem Biophys 1977 0.85
104 Acute and late effects of multimodal therapy on normal tissues. Cancer 1977 0.85
105 Response of a murine solid tumor to in vivo combined chemotherapy and irradiation. Radiology 1973 0.85
106 Whole-lung irradiation for metastatic tumor. Radiology 1969 0.85
107 15 years experience with helium ion radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys 1997 0.85
108 Interaction of radiation and adriamycin on the EMT6 tumor as a function of tumor size and assay method. Int J Radiat Oncol Biol Phys 1979 0.85
109 Identification of a high-risk clinically localized prostate cancer subgroup receiving maximum benefit from whole-pelvic irradiation. Cancer J Sci Am 1999 0.85
110 A randomized trial of accelerated hyperfractionated radiation therapy and bis-chloroethyl nitrosourea for malignant glioma. A preliminary report of Radiation Therapy Oncology Group 83-02. Cancer 1992 0.85
111 Regulation of intestinal goblet cells in situ, in mucosal explants and in the isolated epithelium. Ciba Found Symp 1984 0.84
112 Radioprotection of tumor and normal tissues by thiophosphate compounds. Cancer 1973 0.84
113 Radiation therapy alone or combined with misonidazole in the treatment of locally advanced non-oat cell lung cancer: report of an RTOG prospective randomized trial. Int J Radiat Oncol Biol Phys 1989 0.84
114 Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumors. Int J Radiat Oncol Biol Phys 1998 0.84
115 Radiotherapy for verrucous carcinoma. Radiology 1976 0.84
116 The hypoxic cell sensitizer programme in the United States. Br J Cancer Suppl 1978 0.84
117 Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme. Int J Radiat Oncol Biol Phys 1996 0.84
118 Macromolecules can pass through occluding junctions of rat ileal epithelium during cholinergic stimulation. Cell Tissue Res 1987 0.84
119 Microwave hyperthermia for choroidal melanoma in rabbits. Invest Ophthalmol Vis Sci 1990 0.84
120 Interstitial brachytherapy for newly diagnosed patients with malignant gliomas: the UCSF experience. Int J Radiat Oncol Biol Phys 1992 0.83
121 Intraoperative radiotherapy with localized radioprotection: diminished duodenal toxicity with intraluminal WR2721. Int J Radiat Oncol Biol Phys 1991 0.83
122 Recurrent locally advanced nasopharyngeal carcinoma treated with heavy charged particle irradiation. Int J Radiat Oncol Biol Phys 1992 0.83
123 Nature of the multiple forms of sweet-potato glucose phosphate isomerase. Biochem J 1975 0.83
124 Split-dose recovery in euoxic and hypoxic normal and tumor cells. Radiology 1972 0.82
125 Helium charged particle radiotherapy for meningioma: experience at UCLBL. University of California Lawrence Berkeley Laboratory. Int J Radiat Oncol Biol Phys 1994 0.82
126 Initial pharmacology and toxicology of intravenous desmethylmisonidazole. Int J Radiat Oncol Biol Phys 1982 0.81
127 Treatment of carcinoma of the vocal cord. A review of 20 years experience. Laryngoscope 1981 0.81
128 Promise of radiosensitizers and radioprotectors in the treatment of human cancer. Cancer Treat Rep 1984 0.81
129 Phase I trial of intravenous L-phenylalanine mustard plus the sensitizer misonidazole. Cancer Res 1983 0.81
130 Clinical trials with hypoxic cell sensitizers: time to retrench or time to push forward? Int J Radiat Oncol Biol Phys 1984 0.81
131 The role of radiation therapy in the treatment of osteosarcoma. Radiology 1976 0.80
132 Therapy of liver tumors metastatic from colorectal cancer with whole-liver radiation combined with 5-FU, adriamycin, and methotrexate. Cancer Chemother Pharmacol 1982 0.80
133 Immunosuppression following radiation therapy for carcinoma of the nasopharynx. Am J Roentgenol Radium Ther Nucl Med 1975 0.80
134 Phase I trial of the hypoxic cell radiosensitizer SR-2508: the results of the five to six week drug schedule. Int J Radiat Oncol Biol Phys 1986 0.80
135 Combination chemotherapy and whole lung irradiation for pulmonary metastases from sarcomas and germinal cell tumors of the testis. Cancer 1974 0.80
136 Thermoradiotherapy of recurrent malignant brain tumors. Int J Radiat Oncol Biol Phys 1992 0.80
137 Radiation therapy and bromodeoxyuridine chemotherapy followed by procarbazine, lomustine, and vincristine for the treatment of anaplastic gliomas. Int J Radiat Oncol Biol Phys 1995 0.80
138 Carcinoma of the nasopharynx. Review of 146 patients with emphasis on radiation dose and time factors. Am J Surg 1972 0.80
139 Irradiation with or without misonidazole for patients with stages IIIB and IVA carcinoma of the cervix: final results of RTOG 80-05. Radiation Therapy Oncology Group. Int J Radiat Oncol Biol Phys 1999 0.80
140 Optimization of the oblique angles in the treatment of prostate cancer during six-field conformal radiotherapy. Med Dosim 1994 0.80
141 Final report on phase I trial of WR-2721 before protracted fractionated radiation therapy. Int J Radiat Oncol Biol Phys 1988 0.80
142 Therapy of hepatocellular cancer with combined intrahepatic arterial chemotherapy and whole liver irradiation. Ann Acad Med Singapore 1980 0.80
143 HSP 70 synthesis in clinical hyperthermia patients: preliminary results of a new technique. Int J Radiat Oncol Biol Phys 1994 0.79
144 Uveal melanoma: development of metastases after helium ion irradiation. Radiology 1991 0.79
145 The interaction of irradiation and adriamycin in intestinal crypt cells. Int J Radiat Oncol Biol Phys 1979 0.79
146 Radiation dose response of normal brain. Int J Radiat Oncol Biol Phys 1988 0.79
147 Pathology of delayed radiation brain damage: an experimental canine model. Radiat Res 1987 0.79
148 Combining hyperthermia and radiation: how beneficial? Oncology (Williston Park) 1991 0.79
149 Chemical modification of radiation effects. Cancer 1977 0.79
150 Hyperthermia in cancer therapy. West J Med 1980 0.79
151 A phase I-II trial of heavy charged particle irradiation of malignant glioma of the brain: a Northern California Oncology Group Study. Int J Radiat Oncol Biol Phys 1985 0.78
152 Helium-ion radiation therapy at the Lawrence Berkeley Laboratory: recent results of a Northern California Oncology Group Clinical Trial. Radiat Res Suppl 1985 0.78
153 Combined radiotherapy and multidrug chemotherapy for advanced head and neck cancer: results of a Radiation Therapy Oncology Group pilot study. Cancer Treat Rep 1979 0.78
154 The relationship of SR-2508 sensitizer enhancement ratio to cellular glutathione levels in human tumor cell lines. Int J Radiat Oncol Biol Phys 1986 0.78
155 Variation in sensitizing efficiency for SR 2508 in human cells dependent on glutathione content. Int J Radiat Oncol Biol Phys 1986 0.78
156 Pre-enucleation irradiation of uveal melanoma. Br J Ophthalmol 1985 0.78
157 Radiation brain damage induced by interstitial 125I sources: a canine model evaluated by quantitative computed tomography. Neurosurgery 1985 0.78
158 Clinical trials of hypoxic cell sensitizers. Int J Radiat Oncol Biol Phys 1982 0.78
159 The interaction of drug and radiation effects on normal tissues. Int J Radiat Oncol Biol Phys 1978 0.78
160 Pulsed low dose rate brachytherapy for pelvic malignancies. Int J Radiat Oncol Biol Phys 1997 0.78
161 Biological effects of accelerated heavy ions. II. Fractionated irradiation of intestinal crypt cells. Radiat Res 1981 0.78
162 Radiation therapy of the glomus jugulare tumor. Am J Roentgenol Radium Ther Nucl Med 1973 0.78
163 Precision, high dose radiotherapy. II. Helium ion treatment of tumors adjacent to critical central nervous system structures. Int J Radiat Oncol Biol Phys 1985 0.78
164 Re-irradiation of pituitary adenoma. Int J Radiat Oncol Biol Phys 1992 0.78
165 Uveal melanoma management. Br J Ophthalmol 1989 0.77
166 International Clinical Trials in Radiation Oncology. Chemical modifiers. Int J Radiat Oncol Biol Phys 1988 0.77
167 Clinical problems in radiotherapy of carcinoma of the pancreas. Am J Clin Oncol 1982 0.77
168 In vivo radiobiology of heavy ions. Int J Radiat Oncol Biol Phys 1982 0.77
169 Comparison of helium-ion radiation therapy and split-course megavoltage irradiation for unresectable adenocarcinoma of the pancreas. Final report of a Northern California Oncology Group randomized prospective clinical trial. Radiology 1988 0.77
170 Clinical trials of misonidazole in the United States. Cancer Clin Trials 1981 0.77
171 Late vascular effects of whole brain X-irradiation in the mouse. Acta Neurochir (Wien) 1982 0.77
172 Radiosensitization produced by iododeoxyuridine with high linear energy transfer heavy ion beams. Int J Radiat Oncol Biol Phys 1988 0.77
173 The interaction of radiation and bleomycin in intestinal crypt cells. Int J Radiat Oncol Biol Phys 1979 0.77
174 Tumor biology of helium and heavy ions. Int J Radiat Oncol Biol Phys 1977 0.77
175 Apparent absence of recovery in endogenous colony-forming cells after irradiation under hypoxic conditions. Radiat Res 1968 0.77
176 Sensitizers and protectors in clinical oncology. Semin Oncol 1981 0.77
177 Intraoperative radiation therapy for Wilms' tumor in situ or ex vivo. Cancer 1991 0.77
178 Relative biological effectiveness of low- and high-LET radiotherapy beams for jejunal crypt cell survival at low doses per fraction. Radiology 1979 0.77
179 Neon heavy charged particle radiotherapy of glioblastoma of the brain. Int J Radiat Oncol Biol Phys 1997 0.77
180 Protection of normal tissues by WR2721 during fractionated irradiation. Int J Radiat Oncol Biol Phys 1977 0.76
181 Auger electron contribution to bromodeoxyuridine cellular radiosensitization. Int J Radiat Oncol Biol Phys 1989 0.76
182 Direct-coupled interstitial ultrasound applicators for simultaneous thermobrachytherapy: a feasibility study. Int J Hyperthermia 1997 0.76
183 Heating patterns of the Helios ultrasound hyperthermia system. Int J Hyperthermia 1993 0.76
184 Interstitial brachytherapy of primary brain tumors. Preliminary report. J Neurosurg 1980 0.76
185 Charged particle radiotherapy of paraspinal tumors. Int J Radiat Oncol Biol Phys 1992 0.76
186 Heavy charged particle therapy of bone and soft tissue sarcoma. A phase I-II trial of the University of California Lawrence Berkeley Laboratory and the Northern California Oncology Group. Am J Clin Oncol 1986 0.76
187 Editorial on "The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix". Int J Radiat Oncol Biol Phys 1994 0.76
188 Treatment of locally recurrent carcinoma of the nasopharynx. Radiology 1975 0.76
189 External and interstitial radiation therapy of carcinoma of the oral tongue. A review of 32 years' experience. AJR Am J Roentgenol 1976 0.76
190 Brachytherapy of brain tumors. Stereotact Funct Neurosurg 1992 0.75
191 Radiatio herapy of malignant bone tumors. Radiology 1969 0.75
192 Comment on "survival improvement in anaplastic astrocytoma, combining external radiation with halogenated pyrimidines: final report of RTOG 86-12, Phase I-II Study". Int J Radiat Oncol Biol Phys 1996 0.75
193 Helium charged-particle radiotherapy of locally advanced carcinoma of the esophagus, stomach, and biliary tract. Am J Clin Oncol 1983 0.75
194 Three-dimensional conformal radiation therapy in locally advanced carcinoma of the prostate: preliminary results of a phase I dose escalation study. Int J Radiat Oncol Biol Phys 1994 0.75
195 The role of radiation therapy in myasthenia gravis. Calif Med 1967 0.75
196 Computed tomography analysis of the canine brain: effects of hemibrain X irradiation. Radiat Res 1984 0.75
197 Boron neutron capture therapy: finally come of age? Int J Radiat Oncol Biol Phys 1994 0.75
198 Bone marrow regeneration following fractionated radiation therapy. Int J Radiat Oncol Biol Phys 1980 0.75
199 Primary radiation treatment of colloid carcinoma of the breast: a case report. Cancer 1981 0.75
200 A productivity system for a hospital education department. J Nurs Staff Dev 1990 0.75
201 Radiation-protection and recovery from radiation injury in endotoxin-treated mice: Hematopoietic recovery and sensitivity to a second radiation exposure. USNRDL-TR-1023. Res Dev Tech Rep 1966 0.75
202 Periodic acid-Schiff positive deposits associated with aging in mouse brains. Lab Anim Sci 1983 0.75
203 The role of radiation therapy in clinical Stage I carcinoma of the endometrium. Int J Radiat Oncol Biol Phys 1977 0.75
204 WR-2721 protects against the hematologic toxicity of cyclophosphamide. J Clin Oncol 1986 0.75
205 Applications of asymmetric collimation on linear accelerators. Med Dosim 1995 0.75
206 Logistics in designing clinical trials for etanidazole (SR 2508): an RTOG experience. Int J Radiat Oncol Biol Phys 1992 0.75
207 The RBE of neutrons in vivo. Cancer 1974 0.75
208 Radiation effects in the canine brain evaluated by quantitative computed tomography. Radiology 1982 0.75
209 Combination therapy of a solid murine tumor with 1, 3 bis (2-chloroethyl)-1-nitrosourea and irradiation. Int J Radiat Oncol Biol Phys 1979 0.75
210 Long-term follow-up after high-activity 125I brachytherapy for pediatric brain tumors. Pediatr Neurosurg 1996 0.75
211 Combined treatment methods for carcinoma of the esophagus. Radiology 1978 0.75
212 Peroral roentgen therapy. Radiology 1968 0.75
213 Catamnesis. Int J Radiat Oncol Biol Phys 1977 0.75
214 Immunosuppression and reconstitution with thymosin after radiation therapy. Int J Radiat Oncol Biol Phys 1979 0.75
215 Serum IgA in the diagnosis of nasopharyngeal and paranasal sinus carcinoma. Radiology 1975 0.75
216 Radiation effects renal enlargement in the mouse. Proc Soc Exp Biol Med 1966 0.75
217 Qualitative alteration in radiation injury under hypoxic conditions. Radiology 1968 0.75
218 Misonidazole neurotoxicity in rats: Part I. Evaluation of misonidazole neurotoxicity in rats by analysis of brain stem auditory and cortical evoked potentials. J Neurooncol 1984 0.75
219 Lipid peroxidation does not appear to be a factor in late radiation injury of the cervical spinal cord of rats. Int J Radiat Oncol Biol Phys 1993 0.75
220 Role of radiation therapy in the treatment of supraglottic carcinoma. Cancer 1972 0.75
221 Normal brain iodine-125 radiation damage: effect of dose and irradiated volume in a canine model. Radiology 1986 0.75
222 Cholinergic responsiveness of goblet cells during intestinal maturation. Biol Neonate 1989 0.75
223 Misonidazole and hemibody irradiation in the palliation of widespread metastases. Final report of an RTOG study. Am J Clin Oncol 1985 0.75
224 Stereotactic interstitial irradiation for the treatment of brain tumors. Cancer Treat Rep 1981 0.75
225 Evaluation of the bioavailability of misonidazole (NSC#261037) in capsule and tablet form and pharmacologic effects of daily dosage. Int J Radiat Oncol Biol Phys 1982 0.75
226 Preliminary results in heavy charged particle irradiation of bone sarcoma. Int J Radiat Oncol Biol Phys 1992 0.75
227 Computer assisted treatment planning for 125I ophthalmic plaque radiotherapy. Int J Radiat Oncol Biol Phys 1989 0.75
228 Comparison of RBE values of 15 MeV neutrons for damage to an experimental tumour and some normal tissues. Eur J Cancer 1974 0.75
229 Pediatric preoperative tours. Successful hospital program expands to community. AORN J 1991 0.75
230 Fossil plants and coal: patterns of change in pennsylvanian coal swamps of the illinois basin. Science 1974 0.75
231 The radiotherapeutic management of pulmonary metastases. Int J Radiat Oncol Biol Phys 1977 0.75
232 Combined modality therapy using cytotoxic agents and radiation therapy. Am J Clin Oncol 1988 0.75
233 The potential for radiation sensitizers and radiation protectors combined with radiation therapy in gynecologic cancer. Cancer 1981 0.75
234 Opportunities for improving photon radiotherapy. Hosp Pract (Off Ed) 1985 0.75
235 The value of nonuniform margins for six-field conformal irradiation of localized prostate cancer. Int J Radiat Oncol Biol Phys 1995 0.75
236 Hypoxic cell radiosensitizers in the treatment of malignant brain tumors. Neurosurgery 1980 0.75
237 Radiation modalities in treatment of cancer of the oral cavity. J Prosthet Dent 1972 0.75
238 Thermal dosimetry and clinical requirements. Cancer Res 1979 0.75
239 Benign osteoblastoma of the vertebra. Report of a case with five-year follow-up after irradiation. Radiol Clin Biol 1968 0.75
240 Results of treatment of carcinoma of the base of the tongue, the UCSF experience, 1957-1976. Int J Radiat Oncol Biol Phys 1980 0.75
241 Suppression of cellular proliferation in weanling rat kidneys by short-term fasting. Proc Soc Exp Biol Med 1968 0.75
242 The Radiation Therapy Oncology Group: an update of clinical research activities. Int J Radiat Oncol Biol Phys 1991 0.75
243 Effects of fast neutrons on human skin. Am J Roentgenol Radium Ther Nucl Med 1971 0.75
244 [Late vascular effects in irradiated mice brain: in relation to experimental radionecrosis (author's transl)]. No To Shinkei 1982 0.75
245 Comparison of the Radiation Therapy Oncology Group and American Joint Committee on Cancer staging systems among patients with non-small cell lung cancer receiving hyperfractionated radiation therapy. A report of the Radiation Therapy Oncology Group protocol 83-11. Cancer 1991 0.75
246 Effects of single dose and of fractionated radiation on rabbit bone marrow. Radiology 1973 0.75
247 Evoked potentials in rats with misonidazole neurotoxicity. I. Brain stem auditory evoked potentials. J Neurooncol 1983 0.75
248 The interaction of radiation and cyclophosphamide in intestinal crypt cells. Int J Radiat Oncol Biol Phys 1979 0.75
249 Immunologic competence in adults following thymic irradiation in infancy. Radiology 1977 0.75
250 Biological effects of accelerated heavy ions. I. Single doses in normal tissue, tumors, and cells in vitro. Radiat Res 1981 0.75
251 Development of a computed tomographic scanner for radiation therapy treatment planning. Radiology 1980 0.75
252 Early results of ion beam radiation therapy for sacral chordoma. A Northern California Oncology Group Study. J Neurosurg 1986 0.75
253 Isolation of rabbit muscle glucosephosphate isomerase by a single-step substrate elution. Biochim Biophys Acta 1976 0.75
254 Time, dose and volume factors in interstitial Radium implants of carcinoma of the oral tongue. Radiology 1976 0.75
255 Chemical modifiers of cancer treatment. Int J Radiat Oncol Biol Phys 1984 0.75
256 Influence of amioethylisothiouronium bromide-hydrobromide and hyposia on recovery from radiation injury in mice. Nature 1966 0.75
257 Comparative thermal dosimetry of interstitial microwave and radiofrequency-LCF hyperthermia. Int J Hyperthermia 1989 0.75
258 Misonidazole neurotoxicity in rats: Part II. Effect of pre- and intermittent treatment with pentobarbital on misonidazole neurotoxicity in the rat. J Neurooncol 1984 0.75
259 Is a fourth year necessary in radiation oncology training? Different models and funding mechanisms. Int J Radiat Oncol Biol Phys 1992 0.75
260 Apparent absence of recovery in endogenous colony-forming cells after irradiation under hypoxic conditions. USNRDL-TR-1086. Res Dev Tech Rep 1967 0.75
261 The importance of DQ. Int J Radiat Oncol Biol Phys 1976 0.75
262 Evaluation of misonidazole peripheral neurotoxicity in rats by analysis of nerve trains evoked response. Int J Radiat Oncol Biol Phys 1982 0.75
263 Phase III trial of irradiation plus chemotherapy for patients with hepatic metastases and hepatoma: experience of the Northern California Oncology Group. NCI Monogr 1988 0.75
264 Heavy particle experience in the treatment of human cancer. Prog Clin Biol Res 1983 0.75
265 Permanent and removable implants for the brachytherapy of brain tumors. Int J Radiat Oncol Biol Phys 1981 0.75
266 Clinical experiences with local microwave hyperthermia. Int J Radiat Oncol Biol Phys 1981 0.75
267 Iododeoxyuridine incorporation and radiosensitization in three human tumor cell lines. Int J Radiat Oncol Biol Phys 1992 0.75
268 A neutron collimator for animal irradiations. Med Phys 1975 0.75
269 [Heavy particle radiotherapy at the University of California Lawrence Berkeley Laboratory. Clinical studies by the Northern California Oncology Group]. Strahlenther Onkol 1987 0.75
270 Combined radiotherapy and bleomycin for advanced head and neck cancers: results of a phase I pilot study. Cancer Treat Rep 1981 0.75
271 The interaction of irradiation and BCNU in intestinal crypt cells. Int J Radiat Oncol Biol Phys 1979 0.75
272 Ultra-high dose-rate effects in radiosensitive bacteria. Int J Radiat Biol Relat Stud Phys Chem Med 1969 0.75
273 The relative biological effectiveness (RBE) and oxygen enhancement ratio (OER) of neon ions for the EMT6 tumor system. Radiology 1976 0.75
274 Results of integrated management of supraglottic carcinoma. Cancer 1977 0.75
275 3D conformal radiotherapy in the sagittal plane for centrally located thoracic tumors. Med Dosim 1995 0.75
276 Evaluation of past experience with fast neutron teletherapy and its implications for future applications. Eur J Cancer 1971 0.75
277 Is misonidazole neurotoxicity altered by the use of phenytoin and/or dexamethasone in RTOG 79-18 and RTOG 79-16? Int J Radiat Oncol Biol Phys 1984 0.75
278 Interstitial irradiation and hyperthermia for the treatment of recurrent malignant brain tumors. Neurosurgery 1991 0.75
279 Radiotherapy in cooperative clinical trials: Northern California Oncology Group (NCOG) method. Int J Radiat Oncol Biol Phys 1980 0.75
280 Large fraction radiotherapy plus misonidazole for treatment of advanced lung cancer: report of a phase I/II trial. Int J Radiat Oncol Biol Phys 1982 0.75
281 Altered split-dose recovery in mice irradiated under hypoxic conditions. Radiat Res 1969 0.75
282 Altered-split dose recovery in mice irradiated under hypoxic conditions: NRDL-TR-68-84. Res Dev Tech Rep 1968 0.75